Skip to content
10-Q

Quarterly Report

XBIOTECH INC. XBIT

0001171843-26-003419

← back to feed
Filed
May 14, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 14, 2026 30.49M sh
Capex Q1 2026 · Mar 31, 2026 $0
Capex Q1 2026 · Mar 31, 2025 $94K
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$8.97M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$6.72M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $115.46M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $125.55M
Stockholders Equity Q1 2026 · Mar 31, 2026 $135.02M
Stockholders Equity Q1 2026 · Dec 31, 2025 $140.35M
Stockholders Equity Q1 2026 · Mar 31, 2025 $174.71M
Stockholders Equity Q1 2026 · Dec 31, 2024 $182.27M
Current Liabilities Q1 2026 · Mar 31, 2026 $3M
Current Liabilities Q1 2026 · Dec 31, 2025 $7.93M
Total Liabilities Q1 2026 · Mar 31, 2026 $4.82M
Total Liabilities Q1 2026 · Dec 31, 2025 $9.73M
Current Assets Q1 2026 · Mar 31, 2026 $117.05M
Current Assets Q1 2026 · Dec 31, 2025 $126.95M
Total Assets Q1 2026 · Mar 31, 2026 $139.84M
Total Assets Q1 2026 · Dec 31, 2025 $150.08M
Eps Basic Q1 2026 · Mar 31, 2026 −$0.18
Eps Basic Q1 2026 · Mar 31, 2025 −$0.36
Sga Expense Q1 2026 · Mar 31, 2026 $1.07M
Sga Expense Q1 2026 · Mar 31, 2025 $1.93M
Rd Expense Q1 2026 · Mar 31, 2026 $5.21M
Rd Expense Q1 2026 · Mar 31, 2025 $11.62M
Net Income Q1 2026 · Mar 31, 2026 −$5.51M
Net Income Q1 2026 · Mar 31, 2025 −$10.88M
Operating Income Q1 2026 · Mar 31, 2026 −$6.27M
Operating Income Q1 2026 · Mar 31, 2025 −$13.55M